Get started
Author

Kelly L. Singel

Observed names: K. L. Singel, K. Singel, K.L. Singel, Kelly L Singel, Kelly Singel, Kelly L. Singel
ORCID: 0000-0002-8053-4736
Observed ORCID: 0000-0002-8053-4736
OpenAlex ID: A5066459219
Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry
2017 · Paul C. Mayor, Kevin H. Eng, et al. · Journal of Allergy and Clinical Immunology · 247
NOX2-dependent regulation of inflammation
2016 · Kelly L. Singel, Brahm H. Segal · Clinical Science · 213
Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal
2016 · Kelly L. Singel, Brahm H. Segal · Immunological Reviews · 181
Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment
2019 · Kelly L. Singel, Tiffany R. Emmons, et al. · JCI Insight · 142
PDF
Mitochondrial DNA in the tumour microenvironment activates neutrophils and is associated with worse outcomes in patients with advanced epithelial ovarian cancer
2018 · Kelly L. Singel, Kassondra S. Grzankowski, et al. · British Journal of Cancer · 95
PDF
Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer
2015 · Nonna Kolomeyevskaya, Kevin H. Eng, et al. · Gynecologic Oncology · 87
Monocyte- and Macrophage-Targeted NADPH Oxidase Mediates Antifungal Host Defense and Regulation of Acute Inflammation in Mice
2013 · Melissa J Grimm, R Robert Vethanayagam, et al. · The Journal of Immunology · 80
PDF
Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer
2021 · Tiffany R. Emmons, Thejaswini Giridharan, et al. · Cancer Immunology Research · 74
PDF
Impact of ascites volume on clinical outcomes in ovarian cancer: A cohort study
2017 · J. Brian Szender, Tiffany Emmons, et al. · Gynecologic Oncology · 74
RNA editing enzyme APOBEC3A promotes pro-inflammatory M1 macrophage polarization
2021 · Emad Y. Alqassim, Shraddha Sharma, et al. · Communications Biology · 54
Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer
2015 · Anm Nazmul H. Khan, Nonna Kolomeyevskaya, et al. · Oncotarget · 48
PDF
Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding Basophils
2020 · ANM Nazmul H. Khan, Tiffany R. Emmons, et al. · Cancer Immunology Research · 42
Myeloid-Derived Suppressor Cells Modulate Immune Responses Independently of NADPH Oxidase in the Ovarian Tumor Microenvironment in Mice
2013 · Heidi E. Godoy, A. Nazmul H. Khan, et al. · PLoS ONE · 18
PDF
VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patients
2022 · ANM Nazmul H. Khan, Tiffany R. Emmons, et al. · Cancer Immunology Immunotherapy · 16
PDF
A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer
2021 · A. J. R. McGray, C. Eppolito, et al. · Cancer Immunology Immunotherapy · 12
PDF
Carboplatin enhances lymphocyte-endothelial interactions to promote CD8+ T cell trafficking into the ovarian tumor microenvironment
2022 · Jaron Mark, Dan T. Fisher, et al. · Gynecologic Oncology · 6
Ovarian cancer ascites induces a T cell suppressive phenotype in mature neutrophils: a potential barrier to anti-tumor immunity
2017 · Kelly L Singel, Anm Nazmul H Khan, et al. · The Journal of Immunology · 4
Surgery induces broad changes in clinically relevant genes regulating immune and metabolic responses in murine epithelial ovarian cancer
2019 · P.C. Mayor, S.N. Akers, et al. · Gynecologic Oncology · 2
Cancer in primary immunodeficiency diseases: An analysis of cancer incidence in the United States immune deficiency network (USIDNET) registry.
2016 · Paul Mayor, Kevin H. Eng, et al. · Journal of Clinical Oncology · 2
ARS2-directed alternative splicing mediates CD28 driven T cell glycolysis and effector function
2021 · G. Aaron Holling, Anand P. Sharda, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Abstract 4557: Tumor immune profiling identifies multiple unique therapeutic targets that improve vaccination + oncolytic virotherapy against metastatic ovarian cancer
2017 · AJ Robert Mcgray, Cheryl Eppolito, et al. · Cancer Research · 1
Ovarian cancer ascites-activated neutrophils suppress T cell proliferation in a contact-dependent mechanism
2016 · Kelly L Singel, Anm Nazmul H Khan, et al. · The Journal of Immunology · 1
Data from Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer
2023 · Tiffany R. Emmons, Thejaswini Giridharan, et al.
Data from Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding Basophils
2023 · ANM Nazmul H. Khan, Tiffany R. Emmons, et al.
Data from Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer
2023 · Tiffany R. Emmons, Thejaswini Giridharan, et al.
Works count: 50
Citation count: 1,399
H-index: 14
I10-index: 15
Year
Topic
Type